Literature DB >> 20644065

Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality.

Kelli D Salter1, Peter E Andersen, James I Cohen, Kathyrn G Schuff, Linda Lester, Maisie L Shindo, David Sauer, Neil D Gross.   

Abstract

OBJECTIVE: To determine the risk of nodal metastases to the central compartment from differentiated papillary thyroid carcinoma (PTC) relative to known prognostic variables.
DESIGN: A 7-year single-institutional retrospective review.
SETTING: Tertiary academic center. PATIENTS: A total of 115 patients undergoing central neck dissection (CND) for PTC or follicular variant PTC (FVPTC). MAIN OUTCOME MEASURE: Number, location, and positivity of lymph nodes for malignant disease in the central compartment based on patient age, sex, extrathyroidal extension, and primary tumor size, histologic type, and focality.
RESULTS: Eighty-seven percent of patients had PTC, and 13% had FVPTC. Bilateral (64%) or ipsilateral (36%) CND was performed in patients with PTC. Patients with FVPTC underwent only ipsilateral CND. There was no significant difference in the number of lymph nodes retrieved based on patient age or sex, histologic type of the primary tumor, size or focality, or surgeon or pathologist. Seventy-eight percent of patients with PTC had malignant lymph nodes in the ipsilateral (75%) or bilateral/contralateral (69%) central compartment. Ipsilateral nodal metastases directly correlated with tumor multifocality (r = 0.93; P = .001) and size (r = 0.89; P = .001). Bilateral nodal metastases directly correlated with tumor multifocality (r = 0.92; P = .001) but was independent of size (r = 0.56; P = .001). No malignant lymph nodes were identified in the central compartment of FVPTC.
CONCLUSIONS: Malignant central nodal metastases occur with high frequency in PTC but not in FVPTC. The risk of metastases correlated with the size and multifocality of the primary tumor. Additional studies are warranted to determine the extent of CND in patients with and without known multifocal disease and to determine the role of CND in patients with FVPTC.

Entities:  

Mesh:

Year:  2010        PMID: 20644065     DOI: 10.1001/archoto.2010.112

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  13 in total

1.  Differentiated thyroid tumors: surgical indications.

Authors:  R Lucchini; M Monacelli; S Santoprete; R Triola; C Conti; R Pecoriello; P Favoriti; M S Di Patrizi; I Barillaro; A Boccolini; S Avenia; M D'Ajello; A Sanguinetti; N Avenia
Journal:  G Chir       Date:  2013 May-Jun

2.  Clinical and sonographic assessment of cervical lymph node metastasis in papillary thyroid carcinoma.

Authors:  Qi Wu; Yi-Min Zhang; Si Sun; Juan-Juan Li; Juan Wu; Xiang Li; Shan Zhu; Wen Wei; Sheng-Rong Sun
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-12-07

3.  Thyroid cancers with benign-looking sonographic features have different lymph node metastatic risk and histologic subtypes according to nodule size.

Authors:  Dong Yeob Shin; Young Ki Lee; Kwang Joon Kim; Kyeong Hye Park; Sena Hwang; Se Hee Park; Eun-Kyung Kim; Hyeong Ju Kwon; Eun Jig Lee
Journal:  Endocr Pathol       Date:  2014-12       Impact factor: 3.943

4.  An Update on the Risk of Lymph Node Metastasis for the Follicular Variant of Papillary Thyroid Carcinoma with the New Diagnostic Paradigm.

Authors:  Aleksandra M Sowder; Benjamin L Witt; Jason P Hunt
Journal:  Head Neck Pathol       Date:  2017-06-24

5.  Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features.

Authors:  Kyung-Eun Kim; Eun-Kyung Kim; Jung Hyun Yoon; Kyung Hwa Han; Hee Jung Moon; Jin Young Kwak
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

6.  Is a Prophylactic Central Compartment Neck Dissection Required in Papillary Thyroid Carcinoma Patients with Clinically Involved Lateral Compartment Lymph Nodes?

Authors:  Victoria Harries; Marlena McGill; Laura Y Wang; R Michael Tuttle; Richard J Wong; Ashok R Shaha; Jatin P Shah; Snehal G Patel; Ian Ganly
Journal:  Ann Surg Oncol       Date:  2020-07-17       Impact factor: 5.344

7.  Histological subtype is the most important determinant of survival in metastatic papillary thyroid cancer.

Authors:  Alexandra Chrisoulidou; Maria Boudina; Athanasios Tzemailas; Eleni Doumala; Pashalia K Iliadou; Frideriki Patakiouta; Kalliopi Pazaitou-Panayiotou
Journal:  Thyroid Res       Date:  2011-07-19

8.  Pattern and risk factors of central compartment lymph node metastasis in papillary thyroid cancer: a prospective study from an endocrine surgery centre.

Authors:  Sudhi Agarwal; Gyan Chand; Sushila Jaiswal; Anjali Mishra; Gaurav Agarwal; Amit Agarwal; A K Verma; S K Mishra
Journal:  J Thyroid Res       Date:  2011-09-29

9.  Hemithyroidectomy increases the risk of disease recurrence in patients with ipsilateral multifocal papillary thyroid carcinoma.

Authors:  Xiaolong Li; Cui Zhao; Dandan Hu; Yang Yu; Jin Gao; Wenchuan Zhao; Ming Gao
Journal:  Oncol Lett       Date:  2013-02-19       Impact factor: 2.967

10.  Randomized trial of prophylactic ipsilateral central lymph node dissection in patients with clinically node negative papillary thyroid microcarcinoma.

Authors:  Bo Young Kim; Nayeon Choi; Sun Wook Kim; Han-Sin Jeong; Man Ki Chung; Young- Ik Son
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-10-29       Impact factor: 3.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.